Now RBC, Oppenheimer, Mizuho and Wedbush lowered their PT for Corbus. The new avarage PT is 30.75$, all keep the Outperform rating. Down 18,5% at the moment,3.25$, late breaking oral presentation this weekend at ObesityWeek26 coming up.
Said I would not buy more but I..
$CRBP